NO833016L - Fremgangsmaate for fremstilling av forbindelser med kardiotonisk aktivitet - Google Patents
Fremgangsmaate for fremstilling av forbindelser med kardiotonisk aktivitetInfo
- Publication number
- NO833016L NO833016L NO833016A NO833016A NO833016L NO 833016 L NO833016 L NO 833016L NO 833016 A NO833016 A NO 833016A NO 833016 A NO833016 A NO 833016A NO 833016 L NO833016 L NO 833016L
- Authority
- NO
- Norway
- Prior art keywords
- carbon atoms
- alkyl
- hydrogen
- phenyl
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41080382A | 1982-08-23 | 1982-08-23 | |
| US06/515,799 US4503061A (en) | 1983-07-22 | 1983-07-22 | Substituted phenyl-pyridinones as cardiotonic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO833016L true NO833016L (no) | 1984-02-24 |
Family
ID=27021138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO833016A NO833016L (no) | 1982-08-23 | 1983-08-22 | Fremgangsmaate for fremstilling av forbindelser med kardiotonisk aktivitet |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0102227B1 (enExample) |
| AU (1) | AU555834B2 (enExample) |
| CA (1) | CA1249815A (enExample) |
| DE (1) | DE3379788D1 (enExample) |
| DK (1) | DK382883D0 (enExample) |
| ES (2) | ES525079A0 (enExample) |
| FI (1) | FI832970A7 (enExample) |
| GR (1) | GR78672B (enExample) |
| IE (1) | IE55842B1 (enExample) |
| IL (1) | IL69407A (enExample) |
| NO (1) | NO833016L (enExample) |
| NZ (1) | NZ205342A (enExample) |
| PH (1) | PH18913A (enExample) |
| PT (1) | PT77229B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3433953A1 (de) * | 1984-09-15 | 1986-03-27 | A. Nattermann & Cie GmbH, 5000 Köln | Neue, eine imidazol-gruppe enthaltende 3,4-dihydro-2(1h)-pyridone und2(1h)-pyridone, verfahren zu ihrer herstellung und diese enthaltende arzneimittel |
| GB8502267D0 (en) * | 1985-01-30 | 1985-02-27 | Pfizer Ltd | Quinolone inotropic agents |
| DE3677316D1 (de) * | 1985-10-17 | 1991-03-07 | Smith Kline French Lab | 4(4-oxo-1,4-dihydropyridin-1-yl)phenyl-derivate. |
| US4737511A (en) * | 1986-11-03 | 1988-04-12 | Schering A.G. | Cardiotonic imidazolylphenylpyrrol-2-ones |
| US5164403A (en) * | 1991-04-05 | 1992-11-17 | G. D. Searle & Co. | N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders |
| US5155117A (en) * | 1991-04-12 | 1992-10-13 | G. D. Searle & Co. | 1-arylheteroarylalkyl substituted-1h-1,2,4-triazole compounds for treatment of circulatory disorders |
| AU715603B2 (en) * | 1996-04-03 | 2000-02-03 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| US6001835A (en) * | 1996-04-03 | 1999-12-14 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3718743A (en) * | 1970-11-19 | 1973-02-27 | Merck & Co Inc | 5-phenyl-2-piperidones and 5-phenyl-2-thiopiperidones in compositions and methods for treating pain, fever and inflammation |
| NZ195564A (en) * | 1979-11-26 | 1983-09-30 | Sterling Drug Inc | 5-pyridinyl-2(1h)-pyridinones pharmaceutical compositions intermediate pyridine compounds |
| DE3106460A1 (de) * | 1980-03-03 | 1982-01-28 | Sandoz-Patent-GmbH, 7850 Lörrach | 2(1h)-pyridinon-derivate, ihre herstellung und sie enthaltende pharmazeutische zubereitungen |
| IL65278A0 (en) * | 1981-03-30 | 1982-05-31 | Sterling Drug Inc | 3-amino-5-(substituted)-2(1h)-pyridinones and corresponding 3-cyano compounds,their preparation and pharmaceutical compositions containing them |
-
1983
- 1983-08-02 IL IL69407A patent/IL69407A/xx unknown
- 1983-08-03 AU AU17550/83A patent/AU555834B2/en not_active Ceased
- 1983-08-03 IE IE1840/83A patent/IE55842B1/xx unknown
- 1983-08-18 GR GR72247A patent/GR78672B/el unknown
- 1983-08-19 DE DE8383304802T patent/DE3379788D1/de not_active Expired
- 1983-08-19 FI FI832970A patent/FI832970A7/fi not_active Application Discontinuation
- 1983-08-19 EP EP83304802A patent/EP0102227B1/en not_active Expired
- 1983-08-22 ES ES525079A patent/ES525079A0/es active Granted
- 1983-08-22 CA CA000435061A patent/CA1249815A/en not_active Expired
- 1983-08-22 NO NO833016A patent/NO833016L/no unknown
- 1983-08-22 NZ NZ205342A patent/NZ205342A/en unknown
- 1983-08-22 PH PH29425A patent/PH18913A/en unknown
- 1983-08-22 PT PT77229A patent/PT77229B/pt unknown
- 1983-08-22 DK DK3828/83A patent/DK382883D0/da not_active Application Discontinuation
-
1984
- 1984-04-16 ES ES531663A patent/ES531663A0/es active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| NZ205342A (en) | 1986-01-24 |
| AU555834B2 (en) | 1986-10-09 |
| AU1755083A (en) | 1984-03-01 |
| PT77229B (en) | 1986-03-18 |
| ES8502435A1 (es) | 1985-01-01 |
| EP0102227A2 (en) | 1984-03-07 |
| FI832970A0 (fi) | 1983-08-19 |
| FI832970L (fi) | 1984-02-24 |
| PT77229A (en) | 1983-09-01 |
| CA1249815A (en) | 1989-02-07 |
| ES525079A0 (es) | 1985-01-01 |
| GR78672B (enExample) | 1984-09-27 |
| IE55842B1 (en) | 1991-01-30 |
| EP0102227B1 (en) | 1989-05-03 |
| IL69407A0 (en) | 1983-11-30 |
| DE3379788D1 (en) | 1989-06-08 |
| ES8505994A1 (es) | 1985-06-16 |
| PH18913A (en) | 1985-11-06 |
| IL69407A (en) | 1987-10-20 |
| ES531663A0 (es) | 1985-06-16 |
| FI832970A7 (fi) | 1984-02-24 |
| DK382883D0 (da) | 1983-08-22 |
| EP0102227A3 (en) | 1985-10-30 |
| IE831840L (en) | 1984-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sircar et al. | Cardiotonic agents. 2. Synthesis and structure-activity relationships of 4, 5-dihydro-6-[4-(H-imidazol-1-yl) phenyl]-3 (2H)-pyridazinones: a new class of positive inotropic agents | |
| KR870001167B1 (ko) | 치환된 2-(1h)-퀴놀론의 제조방법 | |
| US4353905A (en) | Substituted 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and 6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones | |
| EP0430709A2 (en) | Benzthiophen derivatives | |
| US4602019A (en) | Indeno[1,2-c]pyridazin-3-one derivatives useful as cardiotonic and antihypertensive agents | |
| EP0510036B1 (en) | 2-substituted 4,5-diphenyl-imidazoles | |
| US4740513A (en) | Methyl substituted imidazol-1-yl quinolones | |
| NO833016L (no) | Fremgangsmaate for fremstilling av forbindelser med kardiotonisk aktivitet | |
| US4503061A (en) | Substituted phenyl-pyridinones as cardiotonic agents | |
| EP0071059B1 (de) | 6-(5-(Omega-(1-Imidazolyl)-alkyl)-thien-2-yl)-3-oxo-2,3,4,5-tetrahydropyridazine und deren Säureadditionssalze, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate | |
| CA1215982A (en) | 2,4-dihydro-5-¬(substituted)phenyl|-4,4- disubstituted-3h-pyrazol-3-ones | |
| EP0149543A1 (en) | Cardiotonic and antihypertensive oxadiazinone compounds | |
| US4968683A (en) | 6-oxo-pyridazine derivatives, a process for their preparation and medicaments containing these compounds | |
| FI75819B (fi) | Foerfarande foer framstaellning av 4,5-dihydro-6-/2-/4-(1h-imidazol-1-yl)fenyl/-alkenylen/ och -alkylen/-3(2h)-pyridazinonderivat. | |
| US4607037A (en) | Cardiotonic 2(1H)-pyridinones | |
| US5108998A (en) | Cardiotonic thiadiazine derivatives | |
| JPS63501218A (ja) | ピリジル−ピリダジノン化合物及びピリジル−ピラゾリノン化合物並びにそれらの充血性心不全治療上の用途 | |
| JPH0255431B2 (enExample) | ||
| US4701453A (en) | Substituted indeno-pyridazinones | |
| JPS6157307B2 (enExample) | ||
| US4526982A (en) | 2,4-Dihydro-5-[(substituted)phenyl]-4,4-disubstituted-3H-pyrazol-3-ones | |
| HU191299B (en) | Process for producing 2/1h/-pyridinone derivatives increasing cardiac action | |
| JPS6325583B2 (enExample) | ||
| US4546102A (en) | 1-(6,7-Dimethoxyquinazol-4-yl)semicarbazides | |
| US3887556A (en) | Antimycotic diphenyl-imidazolyl-pyrimidyl methanes |